Cabaletta Bio (CABA) Shares Issued (2019 - 2025)
Cabaletta Bio's quarterly Shares Issued came in at $277000.0 in Q4 2025, up 2.97% year-on-year from $269000.0 in Q4 2024, and up 1878.57% quarter-over-quarter from $14000.0 in Q3 2025.
Cabaletta Bio has reported Shares Issued for 7 years, with the latest figure at $277000.0 in Q4 2025.
- For the quarter ending Q4 2025, Shares Issued rose 2.97% year-over-year to $277000.0; the trailing twelve-month figure through Dec 2025 stood at $291000.0 (up 8.18% YoY), and the FY2025 full-year result was $291000.0, up 8.18% from the prior year.
- Shares Issued for Q4 2025 stood at $277000.0, up from $14000.0 in the prior quarter.
- The five-year high for Shares Issued was $91.7 million in Q4 2023, with the low at -$2.1 million in Q2 2021.
- Average Shares Issued over 5 years is $6.6 million, with a median of $162000.0 recorded in 2021.
- Peak annual rise in Shares Issued reached 6100.0% in 2021, while the deepest fall reached 1341.5% in 2021.
- Tracing CABA's Shares Issued over 5 years: stood at $60000.0 in 2021, then decreased by 15.0% to $51000.0 in 2022, then surged by 179719.61% to $91.7 million in 2023, then plunged by 99.71% to $269000.0 in 2024, then climbed by 2.97% to $277000.0 in 2025.
- The last three Shares Issued figures came in at $277000.0 (Q4 2025), $14000.0 (Q3 2025), and $269000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | 277,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 277,000.00 |
| Dec 31, 2025 | 277,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Dec 31, 2024 | 269,000.00 |
| Dec 31, 2024 | 269,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Jun 30, 2024 | -980,000.00 |
| Jun 30, 2024 | -980,000.00 |
| Mar 31, 2024 | 1.11 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 91.71 Mn |
| Dec 31, 2023 | 91.71 Mn |
| Jun 30, 2023 | 264,000.00 |
| Jun 30, 2023 | 264,000.00 |
| Mar 31, 2023 | -232,000.00 |
| Mar 31, 2023 | -232,000.00 |
| Sep 30, 2022 | 51,000.00 |
| Sep 30, 2022 | 51,000.00 |
| Dec 31, 2021 | 60,000.00 |
| Dec 31, 2021 | 60,000.00 |
| Sep 30, 2021 | 473,000.00 |
| Sep 30, 2021 | 473,000.00 |
| Jun 30, 2021 | -2.12 Mn |
| Jun 30, 2021 | -2.12 Mn |
| Mar 31, 2021 | 2.17 Mn |
| Mar 31, 2021 | 2.17 Mn |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Jun 30, 2020 | -147,000.00 |
| Jun 30, 2020 | -147,000.00 |
| Mar 31, 2020 | -44,000.00 |
| Mar 31, 2020 | -44,000.00 |
| Dec 31, 2019 | 73.31 Mn |
| Dec 31, 2019 | 73.31 Mn |